source
- Experts Highlight Emerging Strategies and Unmet Needs in Mantle Cell LymphomaDr. Lore Gruenbaum, PhD, recently discussed the evolving landscape of mantle cell lymphoma (MCL) in a presentation titled “New Understandings of Treatments, End Points, and Disease Biology Expand M…
- Simlukafusp Alfa plus atezolizumab shows safety but no benefit over standard care in metastatic kidney cancerA clinical study evaluated the novel immunocytokine simlukafusp alfa combined with atezolizumab, with or without bevacizumab, in patients with unresectable metastatic renal cell carcinoma. The com…